styled-frame-2
News
U.S. FDA approves Shorla Oncology’s IMKELDI oral solution for certain forms of leukemia and...
The U.S. Food and Drug Administration (FDA) has approved Shorla Oncology's IMKELDI (imatinib) oral solution, the first oral liquid form of imatinib to treat...
Roche to acquire Poseida Therapeutics
Roche has entered into a definitive merger agreement to acquire Poseida Therapeutics, a public clinical-stage biopharmaceutical company pioneering donor-derived CAR-T cell therapies.
Based in San...
Attruby, a near complete TTR stabilizer (≥90%), approved by FDA to reduce cardiovascular death...
The U.S. Food and Drug Administration (FDA) has approved BridgeBio Pharma's Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for the treatment...
